Companies › XAIR
Beyond Air Inc (XAIR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001641631 · EDGAR filings · Updated 2026-07-16
Beyond Air Inc (XAIR) has reported institutional ownership of 9.7%, with 28 institutional managers holding positions valued at $966.1K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-16 — SCHEDULE 13G/A filed
- 2026-07-14 — SCHEDULE 13G filed
- 2026-07-09 — Current report (8-K) filed
- 2026-06-26 — Current report (8-K) filed
- 2026-06-26 — Annual report (10-K) filed
- 2026-06-22 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Beyond Air Inc has 28 institutional holders and institutional ownership of 9.7%.
Insider activity
Insiders reported 1 transactions (1 buys, 0 sells) across 2 reporting insiders, with a net reported value of $19.5K.
Data flags from SEC filings
Related companies
BioNano Genomics Inc (BNGO) · Icecure Medical Ltd (ICCM) · JYONG BIOTECH LTD (MENS) · SEASTAR MEDICAL HOLDING CORP (ICU) · BIOAFFINITY TECHNOLOGIES INC (BIAF) · Citius Pharmaceuticals Inc (CTXR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.